Form 8-K - Current report:
SEC Accession No. 0001079973-25-000324
Filing Date
2025-02-26
Accepted
2025-02-26 16:31:24
Documents
16
Period of Report
2025-02-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K toi_8k.htm   iXBRL 8-K 31945
2 LIMITED CONSENT AND AMENDMENT NO. 1 TO FACILITY AGREEMENT ex10x1.htm EX-10.1 84807
3 PRESS RELEASE ex99x1.htm EX-99.1 9817
  Complete submission text file 0001079973-25-000324.txt   375200

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE toi-20250226.xsd EX-101.SCH 3912
5 XBRL DEFINITION FILE toi-20250226_def.xml EX-101.DEF 26804
6 XBRL LABEL FILE toi-20250226_lab.xml EX-101.LAB 37033
7 XBRL PRESENTATION FILE toi-20250226_pre.xml EX-101.PRE 25428
18 EXTRACTED XBRL INSTANCE DOCUMENT toi_8k_htm.xml XML 6174
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 25670653
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)